Date: Feb 2024
I thought for my journal club entry this month a would share these articles that were relevant to the case I presented at the symposium in Auckland in December, as not everyone was there and most people like me hadn’t heard of this syndrome before.
Our neuro-ophthalmologist who reviewed the patient (the day before I presented her!) thought this represented her most likely diagnosis although it is still not confirmed.
A brief synopsis of the case
71 female presenting for surgery for routine decompensating exophoria on background of long standing intermittent peripheral sensory neuropathy, AF, hypertension, thrombocytopenia and lymphocytosis (these were considered not particularly relevant at the time)
Had routine surgery of bilateral LR recessions with great initial result.
Sudden onset of recurrence of XT with diplopia and limitation of elevation and adduction approx. 4/52 post-op
??possible partial 3rdN/haematoma due to platelet issue, improved with steroids, MRI brain didn’t show anything
Motility stabilised but very symptomatic with diplopia so proceeded to further surgery addressing XT and R/L
Again good initial result but again regressed about 4/52 PO – connection was made to this timeline coincided with stopping her steroid cover due to her platelet issue.
Unfortunately things haven’t improved and she has been left with significant XT with diplopia and limitation of OM
She did get a temporary improvement while on steroids but this regressed when steroids weaned off.
We sought an opinion from our Neuro-ophthalmologist to help with a diagnosis/ any treatment.
She had tested negative for MG
Her thoughts-
History of peripheral neuropathy with UL weakness with ophthalmoplegia – likely neurological aetiology for ophthalmic presentation
-variability of exo
– atypical EOM limitation
-regression/relapse post EOM surgery = possible chronic peripheral demyelinating condition
– EOM responsiveness to oral steroid is a possible clue
She felt CANOMAD was a high possibility given clinical presentation and some of her lab results -due with anti-glycolipid antibodie
So when surgery regresses or new EOM limitations present in settings of other neurological symptom – you must think of a neurological cause for the strabismus
CANOMAD is a rare syndrome that belongs to the group of peripheral neuropathies associated with IgM monoclonal gammopathy – clinical features include chronic sensory ataxic neuropathy, ophthalmoplegia, M-protein with cold-agglutinin activity and anti-disialosyl antibodies
Yet another condition to consider for our differential diagnosis list!!!!!!
Happy reading
Jo
3 responses to “CANOMAD Syndrome: Feb 2024”
Great articles and great case Jo! Keen to hear what management your patient has been offered and opted for with this provisional diagnosis…
PS Daniel – great website too, easy navigation – superb job!!!
Lora not Loea ….. hahaha didn’t have my glasses on!
Really interesting case and I agree yet another differential D. to add to our list!
all helps to make us better clinicians. Thanks again
also may congratulate Daniel on the website very easy and readable. Thank you.
Sally